FDA Investigator Linda L Ng
Linda L Ng has inspections in 5 countries as of 25 Aug 2023. Linda L Ng has collaborated with a combined 1701 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
25 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Ireland,
United Kingdom of Great Britain and Northern Ireland,
Japan,
Italy
Co-Investigator(s):
Alice S Tsao,
Amanda L Fyles,
Anderson,
Andrew K Haack, PhD,
Anh M Lac,
Azza Talaat,
Bichsa T Tran,
Binh T Nguyen,
Brian D Nicholson,
Brian R Yaun,
Brooke K Higgins,
Bryan A Galvez,
Carla J Lundi,
Caryn M Mcnab,
CDR Ileana Barreto Pettit,
Charisse K Green,
Chris A Sack,
Chunsheng Cai, PhD,
Colleen F Hoyt,
Connie Hannon Rabel,
Connie L Hannon Rabel,
Daniel J Lahar,
Darren S Brown,
David M Beltran,
Deborah A Greco,
Dennis Cantellops Paite,
Dogbeda F Mackenzie,
Dr. Carmelo Rosa,
Dr. Jason R Caballero,
Eileen A Liu,
Ellen P Madigan,
Eric L Dong, BS,
Erika V Butler,
Evelyn Wong,
Feiyan Jin,
George J Flynn,
James R Fleckenstein,
Jennifer M Gogley,
Joel D Hustedt,
Joey V Quitania,
John L Stevens,
Jolanna A Norton,
Karen C Daugherty,
Keith P Iams,
Kham Phommachanh,
Kim Lthomas Cruse,
Kirtida Patel,
Langer,
Latrecia D Stubbs,
Linda Thai,
Lisa R Jennings,
Lisa R Whitt,
Luis A Dasta,
Marcus F Yambot,
Margaret M Annes,
Mariza M Jafary,
Mark E Parmon,
Melissa J Garcia,
Michael A Charles,
Michael E Maselli,
Michael R Goga,
Michael T Cyrus,
Michele L Obert,
Miguel A Martinez,
Mra Davism,
Mra Mcculloughj,
Paraluman S Leonin,
Patrice S Hall,
Patrick C Klotzbuecher,
Patrick L Wisor,
Pauline N Logan,
Philip M Steele, PhD,
Raymond T Oji,
Rebecca C O Bryan,
Rebecca Rodriguez,
Richard L Rutherford,
Rodney L Tinzie,
Russell J Glapion,
Saleem A Akhtar,
Selene T Torres,
Sharmista Chatterjee,
Sina Shojaee,
State Agency,
Stephen D Brown,
Steven D Kehoe,
Steven M Weinman,
Susant Hadman,
Tajah L Blackburn,
Teresa T Cain,
Terrance L Thomas,
Theresa Kirkham (NMI),
Uduak M Inokon,
Vashti E Bocker,
Vickie L Anderson,
Virgilio F Pacio, CSO,
Xiaohui Shen,
Yasamin Ameri,
Yvette Mlacour Davis,
Zachary L Stamm
Linda L Ng's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2015 | FDA 483 | Neos Therapeutics, LP - Form 483, 2015-06-04 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more